Omega-3s and Cardiovascular Disease
  • Ali, S., Garg, S. K., Cohen, B. E., Bhave, P., Harris, W. S., & Whooley, M. A. (2009). Association between Omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: Data from the Heart and Soul Study. Psychotherapy & Psychosomatics, 78(2), 125-127 [click here].

  • Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., et al. (2009). The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLOS Medicine, 6(4), e1000058 [click here].

  • Ginsberg, G. L., & Toal, B. F. (2009). Quantitative approach for incorporating methylmercury risks and Omega-3 fatty acid benefits in developing species-specific fish consumption. Environmental Health Perspectives, 117(2), 267-275 [click here].

  • Harris, W. S. (2007). Omega-3 fatty acids and cardiovascular disease: A case for Omega-3 Index as a new risk factor. Pharmacolgy Research, 55(3), 217-223 [click here].

  • Kendall-Tackett, K. A. (2009). Psychological trauma and physical health: A psychoneuroimmunology approach to etiology of negative heatlh effects and possible interventions. Psychological Trauma, 1(1), 35-48 [click here].

  • Koski, R. R. (2008). Omega-3-acid ethyl esters (Lovaza) for severe hypertriglyceridemia. P & T, 33(5), 271-281 [click here].

  • McNamara, R. K. (2009). Membrane omega-3 fatty acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder. Cardiovascular Psychiatry & Neurology. [click here] 

  • Patel, J. V., Tracey, I., Hughes, E. A., & Lip, G. Y. H. (2009). Omega-3 polyunsaturated fatty acids: A necessity for a comprehensive secondary prevention strategy. Vascular Health and Risk Management, 5, 801-810 [click here].

  • Schwalfenberg, G. (2006). Omega-3 fatty acids: Their beneficial role in cardiovascular health. Canadian Family Physician, 52, 734-740 [click here].

  • von Schacky, C. (2006). A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vascular Health and Risk Management, 2(3), 251-262 [click here].

  • Yamagishi, K., Nettleton, J. A., Folsom, A. R., & Investigators, A. S. (2008). Plasma fatty acids composition and incident heart failure in middle-aged adults. American Heart Journal, 156(5), 965-974 [click here].

HomeAbout USCSpeaking New Stuff
Evidence-based, With Attitude